Literature DB >> 23252925

Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.

Xudong Li1, Jinsong Jiao, Satoru Shimizu, Itsuki Jibiki, Ken-Ichiro Watanabe, Takashi Kubota.   

Abstract

AIMS: In order to confirm the utility of the voxel-based specific regional analysis system for Alzheimer's disease (VSRAD) in assessing the atrophy of the entorhinal cortex, we investigated whether there were correlations between VSRAD and the scores of neuropsychological tests in the patients with Alzheimer's disease (AD) and mild cognitive impairment.
METHODS: Thirty patients, including 18 AD and 12 mild cognitive impairment patients, were included in this study. VSRAD was performed to assess the atrophy of the entorhinal cortex. The patients were carefully screened with the neuropsychological tests, including Wechsler Adult Intelligence Scale-III (WAIS-III), the Wechsler Memory Scale-Revised, the Alzheimer's Disease Assessment Scale-Cognitive Part (ADAS-cog) and the revised version of Hasegawa's Dementia Scale.
RESULTS: All patients showed atrophy with different degrees in the entorhinal cortex except one case. Z-scores had significant positive correlation with ADAS-cog, and negative correlation with Information subset of WAIS-III (respectively, P = 0.0129 and P = 0.0294). The revised version of Hasegawa's Dementia Scale and the Similarities subsets of the WAIS-III had a tendency of negatively correlating with Z-scores of VSRAD (respectively, P = 0.0532 and P = 0.0635). The Delayed Visual Reproduction subset of the Wechsler Memory Scale-Revised was also found to have a weak negative correlation with Z-scores (P = 0.0609).
CONCLUSIONS: Z-scores of VSRAD were revealed to have a close relation with many neuropsychological tests, especially ADAS-cog and the Information subset of WAIS-III. The results meant that VSRAD was a useful indictor of early diagnosis of AD, closely correlating with the changes of cognitive functions and the progression of the disease.
© 2012 The Authors. Psychiatry and Clinical Neurosciences © 2012 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Year:  2012        PMID: 23252925     DOI: 10.1111/pcn.12002

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract.

Authors:  Winston Thomas Chu; Wei-En Wang; Laszlo Zaborszky; Todd Eliot Golde; Steven DeKosky; Ranjan Duara; David A Loewenstein; Malek Adjouadi; Stephen A Coombes; David E Vaillancourt
Journal:  Neurology       Date:  2021-12-14       Impact factor: 9.910

2.  Olfactory and Imaging Features in Atypical Alzheimer's Disease.

Authors:  Zhang Huihong; Wang Pan; Zhang Chunfeng; Wang Yan; Zhang Hui; Cai Li; Zhou Yuying
Journal:  Transl Neurosci       Date:  2018-02-21       Impact factor: 1.757

3.  Automated PDF highlighting to support faster curation of literature for Parkinson's and Alzheimer's disease.

Authors:  Honghan Wu; Anika Oellrich; Christine Girges; Bernard de Bono; Tim J P Hubbard; Richard J B Dobson
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

4.  Relationship between finger movement characteristics and brain voxel-based morphometry.

Authors:  Junpei Sugioka; Shota Suzumura; Katsumi Kuno; Shiori Kizuka; Hiroaki Sakurai; Yoshikiyo Kanada; Tomohiko Mizuguchi; Izumi Kondo
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

Review 5.  Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease.

Authors:  Michael J Knight; Bryony McCann; Risto A Kauppinen; Elizabeth J Coulthard
Journal:  Front Aging Neurosci       Date:  2016-06-16       Impact factor: 5.750

6.  Utility of VSRAD for diagnosing Alzheimer's disease in patients screened for dementia.

Authors:  Gaku Oshikubo; Akihisa Akahane; Aki Unno; Yukako Watanabe; Emi Ikebuchi; Mamoru Tochigi; Naoki Hayashi
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.